Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system’s allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy. The researchers analysed the molecular mechanisms underlying this tolerance and proposed a pre-clinical allergen-specific immunotherapy approach to improve the treatment and control of this common type of allergy. The full study results were published very recently in the renowned international journal “Allergy”, the official journal of the European Academy of Allergy and Clinical Immunology (EAACI) and one of the top two journals worldwide in the allergy field.
Novel immunotherapy approach to treat... - Lung Conditions C...
Novel immunotherapy approach to treat cat allergy.
Written by
2greys
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
I shall send this link on to my aunt who has a very bad allergic to cats. Thanks 2greys.
Not what you're looking for?
You may also like...
CT scans suggest possible lung destruction in some asthmatics
A novel CT scan-based approach has revealed significant changes in a parameter indicating lung...
How to wash the cat.
1. Lift both lids of the toilet an add 1/8 of a cup of pet shampoo, to
the bowl water.
2. Pick up...
How do I deal with a cat allergy when suffering with Bronchiectasis?
I have Bronchiectasis which has recently worsened, but for over twenty years I have suffered...
NIH clinical trial of remdesivir to treat COVID-19 begins.
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational...
How to give a cat a pill
I am sure a lot of you will have seen this before. It has been around a long time. It is one of...